Balyasny Asset Management

Balyasny Asset Management’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History

Balyasny Asset Management’s Portfolio DRNA Stock Details DRNA Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell
2021 Q3	$5.6M	Buy
2021 Q2	$3.23M	Buy
2021 Q1	$1.97M	Buy
2019 Q1	–	Sell
2018 Q4	$501K	Sell
2018 Q3	$4.97M	Buy